help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koziel, H.
Right arrow Articles by Rose, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koziel, H.
Right arrow Articles by Rose, R. M.

Am. J. Respir. Cell Mol. Biol., Volume 23, Number 4, October, 2000 452-459

Alveolar Macrophages from Human Immunodeficiency Virus-Infected Persons Demonstrate Impaired Oxidative Burst Response to Pneumocystis carinii In Vitro

Henry Koziel, Xiuhong Li, Martine Y. K. Armstrong, Frank F. Richards, and Richard M. Rose*

Division of Pulmonary and Critical Care Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts; and MacArthur Center for Molecular Parasitology, Yale University School of Medicine, New Haven, Connecticut

The alveolar macrophage (AM) oxidative burst response is an important component of microbicidal effector cell function against a variety of potential pathogens in the lungs, although the role against Pneumocystis carinii has not been fully investigated. The goals of this study were to characterize the P. carinii-mediated oxidative burst of AMs from healthy individuals, and to examine the oxidative burst of AMs from human immunodeficiency virus (HIV)-infected persons. For healthy individuals, the AM oxidative burst (measured as hydrogen peroxide [H2O2] production) increased in a time- and concentration-dependent manner in response to P. carinii or to the major surface glycoprotein of P. carinii, gp-A (0.01 to 10 µg/ml), required physical contact of P. carinii with AMs, and was not dependent on organism viability. Enzymatic removal of the surface-associated molecules of P. carinii reduced the oxidative burst to 43% of control (P = 0.01). Blocking the AM mannose receptor reduced the P. carinii-mediated oxidative burst response to 37% of control (P = 0.01). Compared with AMs from healthy individuals, P. carinii-mediated H2O2 production was significantly reduced in AMs from asymptomatic HIV-positive (HIV+) persons with CD4+ counts < 200 cells/mm3 (249 ± 43 relative fluorescence units [RFU] versus 130 ± 44 RFU; mean ± standard error of the mean, P = 0.038) and HIV+ persons with active P. carinii pneumonia (78 ± 40 RFU; P = 0.014), but preserved for HIV+ persons with CD4+ counts > 200 cells/mm3. Importantly, H2O2 production in response to phorbol myristate acetate or serum-opsonized zymosan particles was preserved in all groups studied. Thus, AM oxidative burst, mediated in part via P. carinii gp-A and AM mannose receptor may represent an important host response to P. carinii. A specific impairment of P. carinii-mediated AM oxidative burst in persons with advanced HIV infection may contribute to the pathogenesis of P. carinii pneumonia.


* Current address: Stem Cells, Inc., Sunnyvale, CA.




This article has been cited by other articles:


Home page
J. Immunol.Home page
N. R. Patel, J. Zhu, S. D. Tachado, J. Zhang, Z. Wan, J. Saukkonen, and H. Koziel
HIV Impairs TNF-{alpha} Mediated Macrophage Apoptotic Response to Mycobacterium tuberculosis
J. Immunol., November 15, 2007; 179(10): 6973 - 6980.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. D. Tachado, J. Zhang, J. Zhu, N. Patel, M. Cushion, and H. Koziel
Pneumocystis-mediated IL-8 release by macrophages requires coexpression of mannose receptors and TLR2
J. Leukoc. Biol., January 1, 2007; 81(1): 205 - 211.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
L. Huang, A. Morris, A. H. Limper, J. M. Beck, and on behalf of the ATS Pneumocystis Workshop Partici
An Official ATS Workshop Summary: Recent Advances and Future Directions in Pneumocystis Pneumonia (PCP)
Proceedings of the ATS, November 1, 2006; 3(8): 655 - 664.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. E. Lasbury, P. J. Durant, C. A. Ray, D. Tschang, R. Schwendener, and C.-H. Lee
Suppression of Alveolar Macrophage Apoptosis Prolongs Survival of Rats and Mice with Pneumocystis Pneumonia.
J. Immunol., June 1, 2006; 176(11): 6443 - 6453.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
J. Zhang, S. D. Tachado, N. Patel, J. Zhu, A. Imrich, P. Manfruelli, M. Cushion, T. B. Kinane, and H. Koziel
Negative regulatory role of mannose receptors on human alveolar macrophage proinflammatory cytokine release in vitro
J. Leukoc. Biol., September 1, 2005; 78(3): 665 - 674.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. Zhang, J. Zhu, A. Imrich, M. Cushion, T. B. Kinane, and H. Koziel
Pneumocystis Activates Human Alveolar Macrophage NF-{kappa}B Signaling through Mannose Receptors
Infect. Immun., June 1, 2004; 72(6): 3147 - 3160.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
C. Steele, L. Marrero, S. Swain, A. G. Harmsen, M. Zheng, G. D. Brown, S. Gordon, J. E. Shellito, and J. K. Kolls
Alveolar Macrophage-mediated Killing of Pneumocystis carinii f. sp. muris Involves Molecular Recognition by the Dectin-1 {beta}-Glucan Receptor
J. Exp. Med., December 1, 2003; 198(11): 1677 - 1688.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. D. Swain, S. J. Lee, M. C. Nussenzweig, and A. G. Harmsen
Absence of the Macrophage Mannose Receptor in Mice Does Not Increase Susceptibility to Pneumocystis carinii Infection In Vivo
Infect. Immun., November 1, 2003; 71(11): 6213 - 6221.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S.-J. Yong, Z. Vuk-Pavlovic, J. E. Standing, E. C. Crouch, and A. H. Limper
Surfactant Protein D-Mediated Aggregation of Pneumocystis carinii Impairs Phagocytosis by Alveolar Macrophages
Infect. Immun., April 1, 2003; 71(4): 1662 - 1671.
[Abstract] [Full Text]


Home page
J Intensive Care MedHome page
G. S. Gilmartin and H. Koziel
Pneumocystis Carinii Pneumonia in Adult Non-HIV Disorders
J Intensive Care Med, November 1, 2002; 17(6): 283 - 301.
[Abstract] [PDF]


Home page
Br Med BullHome page
S B Gordon and R C Read
Macrophage defences against respiratory tract infections: The immunology of childhood respiratory infections
Br. Med. Bull., March 1, 2002; 61(1): 45 - 61.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
W. J. Martin II and R. Pasula
Role of Alveolar Macrophages in Host Defense against Pneumocystis carinii
Am. J. Respir. Cell Mol. Biol., October 1, 2000; 23(4): 434 - 435.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2000 American Thoracic Society.
  ATS Best of the Web